In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
Top Cited Papers
- 1 January 2009
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 33 (1), 129-139
- https://doi.org/10.1016/j.leukres.2008.06.028
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Targeted pharmaceutical nanocarriers for cancer therapy and imagingThe AAPS Journal, 2007
- Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for CancerThe American Journal of Pathology, 2007
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemiaCancer, 2002
- ASSESSMENT OF LIPOSOME DELIVERY USING SCINTIGRAPHIC IMAGINGJournal of Liposome Research, 2002
- Idarubicin and High Dose Cytarabine: A New Salvage Treatment for Refractory or Relapsing Non-Hodgkin's LymphomaLeukemia & Lymphoma, 1996
- Screening Methods in Antineoplastic Drug DiscoveryJNCI Journal of the National Cancer Institute, 1990
- Vesicles of variable sizes produced by a rapid extrusion procedureBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986
- Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potentialBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligandsJournal of Theoretical Biology, 1976